iifl-logo

Beta Drugs Ltd Cash Flow Statement

1,790.2
(-1.49%)
Apr 30, 2025|03:40:02 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Beta Drugs Ltd FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

9.88

7.46

6.83

Depreciation

-5.26

-2.57

-2.42

-1.85

Tax paid

-2.9

0.24

-0.07

Working capital

6.55

5.39

-7.9

17.2

Other operating items

Operating

8.26

-2.6

22.11

Capital expenditure

1.61

22.13

1.35

6.94

Free cash flow

9.87

-1.25

29.05

Equity raised

93.65

48.46

30.16

Investing

0.42

4.51

1.61

0

Financing

-3.66

4.61

0.38

4.01

Dividends paid

0

0

0

0

Net in cash

100.28

49.19

63.22

Beta Drugs Ltd : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.